Literature DB >> 15724384

Tumor necrosis factor alpha in patients with acute myocardial infarction.

Maged Ramses Fahim1, Sherine Maher Halim, Iman Kamel.   

Abstract

Acute myocardial infarction (AMI) is a myocardial necrosis occurring due to persistent coronary ischemia, in which inflammation plays an important role and heart failure is a common complication. The present work was undertaken to clarify the role of Tumor Necrosis Factor Alpha (TNF-alpha) in acute myocardial infarction (AMI). The study was conducted on 20 newly diagnosed AMI patients and 10 healthy age and sex matched controls. Sequential estimation of plasma TNF alpha level was carried out at admission, 24 and 48 hours post admission using ELISA. AMI patients showed a significant increase of plasma TNF-alpha level on admission, and 24 hours post admission but not after 48 hours. However, a significant increase was still seen at 48 hours post admission in patients with signs of heart failure but not in those without signs of heart failure. A significant positive correlation was found between plasma TNF-alpha level and CPK level at admission. On the other hand a significant negative correlation was found between these 2 parameters at 24 and 48 hours post admission. It is concluded that TNF-alpha may be an early marker of myocardial damage because of the early increase of its level after ischemic injury instead of being late consequence of extensive tissue necrosis. TNF-alpha level may be an important indicator of the severity of AMI and the occurrence of heart failure.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15724384

Source DB:  PubMed          Journal:  Egypt J Immunol


  7 in total

1.  IKK-2 is required for TNF-alpha-induced invasion and proliferation of human mesenchymal stem cells.

Authors:  Wolfgang Böcker; Denitsa Docheva; Wolf Christian Prall; Virginia Egea; Emmanouil Pappou; Oliver Rossmann; Cvetan Popov; Wolf Mutschler; Christian Ries; Matthias Schieker
Journal:  J Mol Med (Berl)       Date:  2008-07-04       Impact factor: 4.599

2.  Pathological observation of acute myocardial infarction in Chinese miniswine.

Authors:  Chuang Wang; Shao-Xin Wang; Ping-Shuan Dong; Li-Ping Wang; Na-Na Duan; Yan-Yu Wang; Ke Wang; Zhuan-Zhen Li; Li-Juan Wei; Ya-Li Meng; Jian-Xin Cheng
Journal:  Int J Clin Exp Med       Date:  2015-11-15

3.  The protective impact of betaine on the tissue structure and renal function in isoproterenol-induced myocardial infarction in rat.

Authors:  Mohammad Maram Ghartavol; Shiva Gholizadeh-Ghaleh Aziz; Ghader Babaei; Gholam Hossein Farjah; Mohammad Hassan Khadem Ansari
Journal:  Mol Genet Genomic Med       Date:  2019-02-27       Impact factor: 2.183

4.  PTEN gene & TNF-alpha in acute myocardial infarction.

Authors:  Adel H Mahmoud; Nasser M Taha; Madiha Zakhary; Marian S Tadros
Journal:  Int J Cardiol Heart Vasc       Date:  2019-04-29

5.  Revealing Calcium Signaling Pathway as Novel Mechanism of Danhong Injection for Treating Acute Myocardial Infarction by Systems Pharmacology and Experiment Validation.

Authors:  Siyu Guo; Yingying Tan; Zhihong Huang; Yikui Li; Weiyu Liu; Xiaotian Fan; Jingyuan Zhang; Antony Stalin; Changgeng Fu; Zhishan Wu; Penglong Wang; Wei Zhou; Xinkui Liu; Chao Wu; Shanshan Jia; Jinyan Zhang; Xiaoxia Duan; Jiarui Wu
Journal:  Front Pharmacol       Date:  2022-02-23       Impact factor: 5.810

6.  Cardiovascular effects of tumour necrosis factor α antagonism in patients with acute myocardial infarction: a first in human study.

Authors:  Gareth J Padfield; Jehangir N Din; Elena Koushiappi; Nicholas L Mills; Simon D Robinson; Nicholas Le May Cruden; Andrew John Lucking; Stanley Chia; Scott A Harding; David E Newby
Journal:  Heart       Date:  2013-04-10       Impact factor: 7.365

7.  Integrative computational and experimental approaches to establish a post-myocardial infarction knowledge map.

Authors:  Nguyen T Nguyen; Xiaolin Zhang; Cathy Wu; Richard A Lange; Robert J Chilton; Merry L Lindsey; Yu-Fang Jin
Journal:  PLoS Comput Biol       Date:  2014-03-20       Impact factor: 4.475

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.